» Articles » PMID: 28600171

Dalbavancin Treatment of Prosthetic Knee Infection Due to Oxacillin-resistant Staphylococcus Epidermidis

Overview
Date 2017 Jun 11
PMID 28600171
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice.

Gatti M, Barnini S, Guarracino F, Parisio E, Spinicci M, Viaggi B Antibiotics (Basel). 2022; 11(3).

PMID: 35326869 PMC: 8944676. DOI: 10.3390/antibiotics11030406.


Multiple-Dose Dalbavancin Regimens as the Predominant Treatment of Deep-Seated or Endovascular Infections: A Scoping Review.

Cooper M, Preslaski C, Shihadeh K, Hawkins K, Jenkins T Open Forum Infect Dis. 2021; 8(11):ofab486.

PMID: 34738025 PMC: 8562469. DOI: 10.1093/ofid/ofab486.


Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs.

Gatti M, Andreoni M, Pea F, Viale P Drug Des Devel Ther. 2021; 15:3349-3378.

PMID: 34376971 PMC: 8349200. DOI: 10.2147/DDDT.S313756.


Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.

Buzon-Martin L, Zollner-Schwetz I, Tobudic S, Cercenado E, Lora-Tamayo J Antibiotics (Basel). 2021; 10(6).

PMID: 34072670 PMC: 8227288. DOI: 10.3390/antibiotics10060656.


[Prolonged treatment with dalbavancin in prosthetic hip infection by methicillin-resistant Staphylococcus epidermidis].

Trujillano Ruiz A, Mesquida Riera J, Serrano Fabia M, Riera Perez E, Mejia Benard A, Taberner Ferrer M Rev Esp Quimioter. 2019; 32(2):203-204.

PMID: 30868837 PMC: 6441993.